GammaDelta Therapeutics Email Format

Biotechnology ResearchEngland, United Kingdom2-10 Employees

GammaDelta Therapeutics is a London, England-based biotechnology company focused on developing cancer immunotherapies that leverage the distinctive properties of gamma delta T cells. It aims to deliver donor-derived, allogeneic therapies based on Vδ1+ T cells with the potential to improve survival for patients with hematological cancers and solid tumors. The firm has developed proprietary processes to selectively isolate and expand Vδ1+ T cell populations suitable for clinical application.

Its research foundation comes from world-class scientists at King’s College London, the Francis Crick Institute, and the University of Lisbon. Its position within the immuno-oncology field has attracted interest from the pharmaceutical sector.

Sign up for free to view info

Company overview Employee directory